The regulator of G-protein signalling (RGS)-protein family, which has more than 30 members, is an intriguing set of drug targets for central nervous system (CNS) therapeutics. In addition to the ...
As of March 1, 2023, the average one-year price target for Regis is $5.61. The forecasts range from a low of $5.56 to a high of $5.78. The average price target represents an increase of 295.07% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback